These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14078371)

  • 1. ORAL POLIO VACCINATION PROGRAM IN HILLSBOROUGH COUNTY USING A SABIN TRIVALENT VACCINE.
    NEILL JS; BURKE SK; BOND JO; SCHNEIDER NJ
    South Med J; 1963 Nov; 56():1239-44. PubMed ID: 14078371
    [No Abstract]   [Full Text] [Related]  

  • 2. Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study.
    Taniuchi M; Famulare M; Zaman K; Uddin MJ; Upfill-Brown AM; Ahmed T; Saha P; Haque R; Bandyopadhyay AS; Modlin JF; Platts-Mills JA; Houpt ER; Yunus M; Petri WA
    Lancet Infect Dis; 2017 Oct; 17(10):1069-1079. PubMed ID: 28693854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THE IMMUNIZING EFFECT OF A TWO-DOSE TRIVALENT ORAL POLIO VACCINE.
    CLAYTON LB; FLIPSE ME; HOFFERT WR; CROSSLEY MI
    Curr Ther Res Clin Exp; 1965 Jan; 7():1-6. PubMed ID: 14246364
    [No Abstract]   [Full Text] [Related]  

  • 4. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.
    Shimizu H
    Vaccine; 2016 Apr; 34(16):1975-85. PubMed ID: 25448090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
    Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
    J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis.
    Foiadelli T; Savasta S; Battistone A; Kota M; Passera C; Fiore S; Bino S; Amato C; Lozza A; Marseglia GL; Fiore L
    BMC Infect Dis; 2016 Jun; 16():277. PubMed ID: 27287521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [VIROLOGICAL STUDY DONE IN RELATION TO THE FIELD OF ORAL SABIN POLIO VACCINE].
    PEREZGALLARDO F; VALENCIANOCLAVEL L; GABRIELYGALAN J
    Rev Sanid Hig Publica (Madr); 1964; 38():502-10. PubMed ID: 14230442
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relative immunity to poliomyelitis in children from 0 to 10, after the 4th National Polio Vaccination Day with trivalent oral type Sabin vaccination, in the area of greater São Paulo, SP (Brazil), 1982].
    Barbosa V; Waldman EA; Fujita M; Kitamura C; Waldman CC; Lacerda JP
    Rev Saude Publica; 1984 Feb; 18(1):19-29. PubMed ID: 6328635
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy.
    Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G
    Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. POLIO VACCINE LIVE ORAL (SABIN) (ADMINISTRATION IN BOMBAY TO SMALL GROUPS).
    MEHERHOMJI KM; RAO VK; DAVE KH; GHARPURE PV; JHALA HI
    Indian J Pathol Bacteriol; 1964 Apr; 55():74-85. PubMed ID: 14157679
    [No Abstract]   [Full Text] [Related]  

  • 11. Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication.
    Cáceres VM; Sutter RW
    Clin Infect Dis; 2001 Aug; 33(4):531-41. PubMed ID: 11462191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating cessation of the type 2 oral polio vaccine by modeling pre- and post-cessation detection rates.
    Kroiss SJ; Famulare M; Lyons H; McCarthy KA; Mercer LD; Chabot-Couture G
    Vaccine; 2017 Oct; 35(42):5674-5681. PubMed ID: 28890193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Complications of polio vaccination with Sabin vaccine].
    Ammundsen E
    Fra Sundhedsstyr; 1968 Mar; 4(25):337-8. PubMed ID: 5758675
    [No Abstract]   [Full Text] [Related]  

  • 14. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.
    Minor PD
    Methods Mol Biol; 2016; 1387():1-10. PubMed ID: 26983727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CONSIDERATIONS ON REACTIVE MANIFESTATIONS AFTER SABIN ANTI-POLIO VACCINATION].
    MORRONE G
    Pediatria (Napoli); 1964 Dec; 72():1363-9. PubMed ID: 14255392
    [No Abstract]   [Full Text] [Related]  

  • 16. The polio endgame.
    Minor P
    Hum Vaccin Immunother; 2014; 10(7):2106-8. PubMed ID: 25608050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.
    Qiu J; Yang Y; Huang L; Wang L; Jiang Z; Gong J; Wang W; Wang H; Guo S; Li C; Wei S; Mo Z; Xia J
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-10. PubMed ID: 28362135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the problem of vaccination reactions following oral immunization by poliomyelitis virus type I (Sabin)].
    LENNARTZ H
    Dtsch Med Wochenschr; 1963 Apr; 88():884-6. PubMed ID: 13929634
    [No Abstract]   [Full Text] [Related]  

  • 20. SAFETY OF SABIN ORAL POLIOVACCINE STRAINS; MASS IMMUNIZATION PROGRAM IN LOS ANGELES COUNTY, 1962-1963.
    WEHRLE PF; LEEDOM JM; PORTNOY B; PIERCE NF; COWPER HH
    JAMA; 1963 Nov; 186():821-6. PubMed ID: 14061062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.